Betapace Tablet
Product Images NDC 83107-006

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Betapace (NDC 83107-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharma Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
A line graph depicting an age factor curve, with the x-axis representing age in months and the y-axis representing the age factor. The graph shows a steep increase in age factor from near 0 at 0.1 months to nearly 1.0 at over 24 months.*
FDA Label Image

Structural Formula (Image 02)

Structural Formula (Image 02)
Chemical structure of sotalol hydrochloride, showing the molecular arrangement including a phenyl ring, sulfonamide group, hydroxyl group, and hydrochloride salt.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A Kaplan-Meier survival curve graph comparing recurrence-free survival over time (days) among groups receiving 80 mg, 120 mg, and 160 mg oral sotalol and a placebo group. The graph includes p-values indicating statistical comparisons between oral sotalol doses and placebo.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
A Kaplan-Meier survival curve chart comparing recurrence-free survival over time in days for oral sotalol versus placebo. The vertical axis shows recurrence-free survival probability (0 to 1.0), and the horizontal axis shows time in days up to 180. Two survival curves are shown, one labeled BETAPACE AF (oral sotalol) and the other Placebo, with a reported log-rank P-value of 0.002 indicating statistical comparison between groups.*
FDA Label Image

Principal Display Panel (80 mg Betapace)

Principal Display Panel (80 mg Betapace)
BETAPACE 80 mg oral tablets label showing sotalol hydrochloride as the active ingredient. The label indicates a package of 100 tablets, manufactured by Legacy Pharma USA, Inc. Storage instructions note keeping at 25°C with permitted excursions. The label also states the product is made in Spain and includes NDC 83107-005-10.*
FDA Label Image

Principal Display Panel (120 mg Betapace)

Principal Display Panel (120 mg Betapace)
Betapace 120 mg (sotalol hydrochloride) oral tablets packaging label showing 100 tablets. Label includes storage instructions, barcode, NDC 83107-006-10, and indicates product is manufactured for Legacy Pharma USA, Inc. in Barbados and made in Spain. Revision date 6/23.*
FDA Label Image

Principal Display Panel (160 mg Betapace)

Principal Display Panel (160 mg Betapace)
Betapace 160 mg tablet label for sotalol hydrochloride oral tablets. The label shows a package of 100 tablets manufactured by Legacy Pharma USA, Inc. It includes storage instructions and dosage information references. The label highlights the 160 mg strength in a red box and specifies it is prescription only.*
FDA Label Image

Principal Display Panel (80 mg Betapace AF)

Principal Display Panel (80 mg Betapace AF)
BETAPACE AF 80 mg oral tablet packaging label contains sotalol hydrochloride as the active ingredient. The label indicates a 60-tablet unit of use and notes storage instructions, dosage directions, and that it is Rx only. It is manufactured for Legacy Pharma Inc., St. Michael, Barbados, and made in Spain, with a revision date of 7/23.*
FDA Label Image

Principal Display Panel (120 mg Betapace AF)

Principal Display Panel (120 mg Betapace AF)
BETAPACE AF 120 mg oral tablet packaging label by Legacy Pharma USA, Inc. The label states each tablet contains 120 mg of sotalol hydrochloride. It is a 60-tablet unit of use for prescription use only. Storage instructions indicate 25°C with excursions between 15-30°C. The product is manufactured for Legacy Pharma Inc., St. Michael, Barbados, and made in Spain.*
FDA Label Image

Principal Display Panel (160 mg Betapace AF)

Principal Display Panel (160 mg Betapace AF)
BETAPACE AF 160 mg tablet label with sotalol hydrochloride as the active ingredient. This oral tablet is presented in a patient pack of 60 tablets. The label includes storage instructions and specifies that the product is manufactured for Legacy Pharma Inc., St. Michael, Barbados, and made in Spain. The label also states it is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.